These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32860238)

  • 1. Advances in fungal chemical genomics for the discovery of new antifungal agents.
    Xue A; Robbins N; Cowen LE
    Ann N Y Acad Sci; 2021 Jul; 1496(1):5-22. PubMed ID: 32860238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Approaches to Antifungal Drug Target Identification and Validation.
    Robbins N; Cowen LE
    Annu Rev Microbiol; 2022 Sep; 76():369-388. PubMed ID: 35650665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents.
    Tripathi H; Luqman S; Meena A; Khan F
    Curr Drug Targets; 2014 Jan; 15(1):136-49. PubMed ID: 24102473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Evolution of Antifungal Drug Resistance.
    Robbins N; Caplan T; Cowen LE
    Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.
    Thammahong A; Puttikamonkul S; Perfect JR; Brennan RG; Cramer RA
    Microbiol Mol Biol Rev; 2017 Jun; 81(2):. PubMed ID: 28298477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
    Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
    Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.
    Roemer T; Jiang B; Davison J; Ketela T; Veillette K; Breton A; Tandia F; Linteau A; Sillaots S; Marta C; Martel N; Veronneau S; Lemieux S; Kauffman S; Becker J; Storms R; Boone C; Bussey H
    Mol Microbiol; 2003 Oct; 50(1):167-81. PubMed ID: 14507372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical-Genetic Approaches for Exploring Mode of Action of Antifungal Compounds in the Fungal Pathogen Candida albicans.
    Robbins N; Ketela T; Kim SH; Cowen LE
    Methods Mol Biol; 2023; 2658():145-165. PubMed ID: 37024700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
    Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens.
    Robbins N; Spitzer M; Yu T; Cerone RP; Averette AK; Bahn YS; Heitman J; Sheppard DC; Tyers M; Wright GD
    Cell Rep; 2015 Nov; 13(7):1481-1492. PubMed ID: 26549450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Fungus-Specific Targets and Inhibitors Using Chemical Phenotyping of Pathogenic Spore Germination.
    Ortiz SC; Huang M; Hull CM
    mBio; 2021 Aug; 12(4):e0167221. PubMed ID: 34311572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
    Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
    Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bigger Data Approach to Analysis of Essential Oils and Their Antifungal Activity against
    Powers CN; Satyal P; Mayo JA; McFeeters H; McFeeters RL
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of New Antifungal Agents Targeting Chitin Synthesis by a Chemical-Genetic Method.
    Li Y; Sun H; Zhu X; Bian C; Wang Y; Si S
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of yeast genomic assays for drug and target discovery.
    Smith AM; Ammar R; Nislow C; Giaever G
    Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical-genetic approaches for exploring the mode of action of natural products.
    Lopez A; Parsons AB; Nislow C; Giaever G; Boone C
    Prog Drug Res; 2008; 66():237, 239-71. PubMed ID: 18416308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches to identify novel targets for future development of antifungal agents.
    Maresca B; Bennett J; Fonzi W; Hitchcock CA; Lodge JK; Williamson PR
    J Med Vet Mycol; 1994; 32 Suppl 1():287-98. PubMed ID: 7722794
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009).
    Espinel-Ingroff A
    Rev Iberoam Micol; 2009 Mar; 26(1):15-22. PubMed ID: 19463273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the biology of a fungal meningitis pathogen using chemical genetics.
    Brown JCS; Nelson J; VanderSluis B; Deshpande R; Butts A; Kagan S; Polacheck I; Krysan DJ; Myers CL; Madhani HD
    Cell; 2014 Nov; 159(5):1168-1187. PubMed ID: 25416953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.